| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 03/16/2006 | US20060057153 Method and composition for the inhibition of mitosis |
| 03/16/2006 | US20060057143 Diagnostics and therapeutics for diseases associated with chemokine receptor 11 (ccr11) |
| 03/16/2006 | US20060057130 An isolated RNA-pulsed antigen presenting cell comprising tumor specific RNA; stimulation of cytotoxic T-lymphocyte proliferation ex vivo or in vivo for adoptive immunotherapy; anticarcinogenic agents; antitumor agents; bactericides; viricides |
| 03/16/2006 | US20060057104 Methods for stimulating tlr irf3 pathways for inducing anti-microbial, anti-inflammatory and anticancer responses |
| 03/16/2006 | US20060057029 Analytical biochemistry system with robotically carried bioarray |
| 03/16/2006 | US20060055273 Screening assay based on rhe sod-3 promotor for the identification of compounds modulating akt or upstream regulators such as insulin igf-1 receptors |
| 03/16/2006 | US20060054941 Multifunctional biosensor based on ZnO nanostructures |
| 03/16/2006 | US20060054228 Microfabricated elastomeric valve and pump systems |
| 03/16/2006 | US20060053870 System and method for detecting particles |
| 03/16/2006 | US20060053652 Freeze-drying microscope stage apparatus and process of using the same |
| 03/16/2006 | DE102004044201A1 Composition for detecting and differentiating renal tumors, containing DNA probes for specific chromosomes, to detect abnormalities indicating clear cell, chromophilic, chromophobic or oncocytoma tumors |
| 03/16/2006 | DE102004042822A1 Verbindungen und Methoden zur Behandlung, Diagnose und Prognose bei Pankreaserkrankungen Compounds and methods for the treatment, diagnosis and prognosis in pancreatic diseases |
| 03/16/2006 | DE102004038359A1 Sequencing nucleic acids for e.g. analyzing genomes, comprises contacting nucleic acid-degrading enzymes with free fluorescent labeled nucleic acids, and determining base sequence |
| 03/16/2006 | DE102004038163A1 Fluoreszenz-basierte Assays zur schnellen, quantitativen Analyse von Biomolekülen (Proteine und Nukleinsäuren) durch Anreicherung auf Zellen oder Beads Fluorescence-based assays for rapid, quantitative analysis of biomolecules (proteins and nucleic acids) by accumulation on cells or beads |
| 03/16/2006 | DE102004038134A1 New multivalent chelator compounds containing a carbohydrate scaffold structure linked to chelator groups and coupling groups useful for modification and/or immobilization of target molecules e.g. proteins that carry an affinity-tag |
| 03/16/2006 | DE102004037927A1 Process and assembly to determine the quantity of biological impurities in swimming pool water by reaction with agent |
| 03/16/2006 | DE102004037860A1 Turmormarker zur Diagnose von Karzinomen und/oder davon abstammender Metastasen Tumor markers in the diagnosis of carcinomas and / or metastases derived therefrom |
| 03/16/2006 | DE102004023439B4 Nachweis von RNA über Micro-Arrays Detection of RNA on microarrays |
| 03/16/2006 | DE102004017750B4 Analyse-Array mit heizbaren Elektroden Analysis array with heatable electrodes |
| 03/16/2006 | DE102004001582B4 Verfahren zur Herstellung von DNS-Sonden für DNS-Abschnitte mit repetitiven Sequenzen Process for the preparation of DNA probes for DNA segments with repetitive sequences |
| 03/16/2006 | CA2580145A1 Amplification blocker comprising intercalating nucleic acids (ina) containing intercalating pseudonucleotides (ipn) |
| 03/16/2006 | CA2579885A1 Association of protein polymorphisms with coronary heart disease |
| 03/16/2006 | CA2579859A1 Decreasing potential iatrogenic risks associated with influenza vaccines |
| 03/16/2006 | CA2579802A1 Methods and compositions for measuring natriuretic peptides and uses thereof |
| 03/16/2006 | CA2579705A1 Method of diagnosing and/or predicting the development of an allergic disorder |
| 03/16/2006 | CA2579558A1 Cancer-testis antigens |
| 03/16/2006 | CA2579349A1 Agents for treatment or prevention of an allergic disorder |
| 03/16/2006 | CA2579285A1 Assessment of ctla-4 polymorphisms in ctla-4 blockade therapy |
| 03/16/2006 | CA2579170A1 Crystal structure of house dust mite allergen der p 1 |
| 03/16/2006 | CA2577819A1 Methods for assessing atherosclerosis |
| 03/16/2006 | CA2576624A1 Genes, compositions, kits, and methods for identification, assessment, prevention, and therapy of prostate cancer |
| 03/16/2006 | CA2575681A1 Compositions comprising a lithium salt, a surfactant and a dna spiking solution and methods of use for purifying dna on a solid support |
| 03/16/2006 | CA2573231A1 Test device for ldl-cholesterol |
| 03/16/2006 | CA2572178A1 Method for distinguishing methicillin resistant s. aureus from methicillin sensitive s. aureus in a mixed culture |
| 03/16/2006 | CA2562285A1 Comparative genomic resequencing |
| 03/15/2006 | EP1635177A1 Quantitation of enzyme activity using planar waveguides |
| 03/15/2006 | EP1635162A2 Devices and methods for detection of an analyte based upon light interference |
| 03/15/2006 | EP1635160A2 Nanostepper/sensor systems and methods of use thereof |
| 03/15/2006 | EP1634967A1 A transcript mapping method |
| 03/15/2006 | EP1634966A2 Methods for detection of nucleic acid sequences in urine |
| 03/15/2006 | EP1634965A1 Real time PCR with the addition of pyrophosphatase |
| 03/15/2006 | EP1634964A2 Method for determining protein binding sites in genomic DNA |
| 03/15/2006 | EP1634963A1 Methods of nucleic acid amplification and sequencing |
| 03/15/2006 | EP1634962A1 Method of detecting target nucleotide sequence, detection target structure to be used in embodying the method, process for producing the same and assay kit for detecting target nucleotide sequence |
| 03/15/2006 | EP1634961A1 FMO3 gene polymorphisms |
| 03/15/2006 | EP1634960A1 Probes for analyzing interaction between proteins and method of analyzing interaction between proteins using the same |
| 03/15/2006 | EP1634959A2 Method of designing probe set, microarray using it, and computer readable medium with a program for executing the said method |
| 03/15/2006 | EP1634953A2 Platelet-activating factor acethylhydrolase |
| 03/15/2006 | EP1634951A1 Novel protein |
| 03/15/2006 | EP1634950A1 Method of preparing gene expression profile |
| 03/15/2006 | EP1634892A2 Composition and methods for the diagnosis of tumours |
| 03/15/2006 | EP1634890A1 Invasive cleavage of nucleic acids |
| 03/15/2006 | EP1634618A1 Method for identifying compounds that increase bone mineral density |
| 03/15/2006 | EP1634603A1 Treatment of transformed or infected biologic Cells |
| 03/15/2006 | EP1634600A1 Antiallergic composition |
| 03/15/2006 | EP1634075A1 Electronic device for communication with living cells |
| 03/15/2006 | EP1634074A2 Hydrolytic substrates for an analyte-dependent enzyme activation system |
| 03/15/2006 | EP1634066A1 Structure and manufacturing method of disposable electrochemical sensor strip |
| 03/15/2006 | EP1634050A2 Colorimetric and fluorescent methods for sensing of oligonucleotides |
| 03/15/2006 | EP1633893A2 Compositions, methods and kits for determining the presence of trichomonas vaginalis in a test sample |
| 03/15/2006 | EP1633892A2 Detection methods for disorders of the lung |
| 03/15/2006 | EP1633891A2 3' biased detection of nucleic acids |
| 03/15/2006 | EP1633890A2 METHODS AND COMPOSITIONS FOR ENHANCING THE EFFICACY AND SPECIFICITY OF FNAi |
| 03/15/2006 | EP1633889A2 Gene expression profiles that identify genetically elite ungulate mammals |
| 03/15/2006 | EP1633888A2 Means and method for the detection of target nucleotide sequences using ligation assays with improved oligonucleotide probe pairs |
| 03/15/2006 | EP1633887A2 Fast method for detecting micro-organisms in food samples |
| 03/15/2006 | EP1633886A2 Optical sensors based on hybrid aptamer/conjugated polymer complexes |
| 03/15/2006 | EP1633885A2 Methods for predicting drug efficacy in patients afflicted with hypertension |
| 03/15/2006 | EP1633884A1 Identification of clonal cells by repeats in (eg.) t-cell receptor v/d/j genes |
| 03/15/2006 | EP1633883A1 Method for assaying lkb1 phosphorylation activity |
| 03/15/2006 | EP1633882A1 Diagnostics and therapeutics for diseases associated with puromycin-insensitive leucyl-specific aminopeptidase (pils) |
| 03/15/2006 | EP1633881A1 Assay for identifying inhibitors of mycobacterium anti-oxidant defense system |
| 03/15/2006 | EP1633880A2 Mptens as modifiers of the pten/igf pathway and methods of use |
| 03/15/2006 | EP1633879A1 Methods for assessing the invasive potential of a cell employing chromatin analysis |
| 03/15/2006 | EP1633873A1 Bacteria with increased levels of protein secretion, nucleotide sequences coding for a seca protein with increased levels of protein secretion, and method for producing proteins |
| 03/15/2006 | EP1633871A1 Double-stranded nucleic acid |
| 03/15/2006 | EP1633870A1 Process |
| 03/15/2006 | EP1633866A1 New biological entities and the pharmaceutical or diagnostic use thereof |
| 03/15/2006 | EP1633865A1 New biological entities and the use thereof |
| 03/15/2006 | EP1633864A2 High throughput assay of lp-pla2 activity |
| 03/15/2006 | EP1633862A2 Method for production of c30-aldehyde carotenoids |
| 03/15/2006 | EP1633856A2 Marks as modifiers of the pten pathway and methods of use |
| 03/15/2006 | EP1633854A2 Gene expression profiling in primary ovarian serous papillary tumors and normal ovarian epithelium |
| 03/15/2006 | EP1633852A2 Sppls as modifiers of the p53 pathway and methods of use |
| 03/15/2006 | EP1633785A2 Human monoclonal antibodies against bacillusanthracis protective antigen |
| 03/15/2006 | EP1633769A1 Novel transcription factor, bp1 |
| 03/15/2006 | EP1633474A1 Device for holding and detecting substance libraries |
| 03/15/2006 | EP1633381A2 Assays using amyloid precursor proteins with modified beta-secretase cleavage sites to monitor beta-secretase activity |
| 03/15/2006 | EP1633356A1 Treatment of tay sachs or sandhoff diseases by enhancing hexosaminidase activity |
| 03/15/2006 | EP1633308A2 Hiv-1 envelope glycoproteins having unusual disulfide structure |
| 03/15/2006 | EP1633302A2 Modulation of apolipoprotein (a) expression |
| 03/15/2006 | EP1633189A2 Truncated fragments of alpha-synuclein in lewy body disease |
| 03/15/2006 | EP1579216A4 Loc169505 as modifier of the apc and axin pathways and methods of use |
| 03/15/2006 | EP1546983A4 Controlled aligment of nano-barcodes encoding specific information for scanning probe microscopy (spm) reading |
| 03/15/2006 | EP1513869A4 Polynucleotides for the detection and quantification of hepatitis b virus nucleic acids |
| 03/15/2006 | EP1512004B1 Method for mapping and eliminating t-cell epitopes |
| 03/15/2006 | EP1499745A4 Characterization of single stranded nucleic acids by melting analysis of secondary structure using double strand-specific nucleic acid dye |
| 03/15/2006 | EP1470155B1 Pluripotency determining factor and uses thereof |
| 03/15/2006 | EP1466014A4 Chemical and biological hazard sensor system and methods thereof |
| 03/15/2006 | EP1445328B1 Atp measurement method allowing visual judgement and reagent therefor |